Europe Continuous Glucose Monitoring Systems - Growing Technology Trends and Business Opportunities by Top Key Players

Europe Continuous Glucose Monitoring Systems Market and is projected to reach $792 million by 2022, supported by a CAGR of 44.9% during the forecast period. The Europe continuous glucose monitoring systems market is the second largest market of the global continuous glucose monitoring systems market. Continuous glucose monitoring systems (CGMS) are used to constantly monitor glucose levels in diabetic patients, thereby helping in reducing the risk of developing long-term diabetic complications by stabilizing the elevated glucose levels.

The Europe continuous glucose monitoring systems market is expected to witness significant growth from 2016 to 2022, owing to numerous advantages of CGMS such as minimal invasiveness and real-time blood glucose monitoring. In addition, increase in per capita healthcare expenditure, increase in incidence of diabetes in Europe, and growth in purchasing power due to high disposable income of individuals are expected to fuel the EU CGMS market growth. Furthermore, the ability of CGMS to provide detailed analysis of blood glucose levels and higher precision as compared to traditional blood glucose monitoring supplements this growth. However, high costs associated with CGMS, lack of adequate reimbursement policies, and stringent government regulations restrict the global continuous glucose monitoring systems market as well as Europe continuous glucose monitoring systems market.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/862

Key players profiled in this report include
• Abbott Laboratories
• DexCom Inc.
• Echo Therapeutics Inc.
• Insulet Corporation
• Johnson & Johnson
• Medtronic plc
• Senseonics Holding Inc.
• F. Hoffmann-La Roche Ltd.

Other players operating in this market include AgaMatrix, Inc., GlySure, OrSense, and Ypsomed.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/862

KEY MARKET SEGMENTS

The European continuous glucose monitoring systems market segmentation is as follows:

By Component
• Sensors
• Transmitters & Receivers
• Integrated Insulin Pumps

By Demographics
• Adult Population
• Child Population
• By End User
• Diagnostics/Clinics
• ICUs
• Home Healthcare

By Country
• Germany
• France
• UK
• Spain
• Italy
• Netherlands
• Norway
• Sweden
• Denmark
• Finland
• Rest of Europe

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/862

KEY BENEFITS FOR STAKEHOLDERS
• This Europe continuous glucose monitoring systems market report provides an extensive analysis of the current EU CGMS market trends and future estimations.
• The market scenario is comprehensively analyzed with respect to the components, demographics, and end users.
• Market estimations are based on high-end analysis of the key developments from 2014 to 2022.
• Recent developments and key manufacturers are listed to understand the competitive market scenario.
• In-depth analysis based on geography provides an understanding of the regional market, which assists in strategic business planning.

Access Full Summery @ https://www.alliedmarketresearch.com/Europe-Continuous-Glucose-Monitoring-Systems-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.